$ALOT
AstroNova, Inc.

2016 Q2 Form 10-Q Financial Statement

#000119312516613905 Filed on June 06, 2016

View on sec.gov

Income Statement

Concept 2016 Q2 2015 Q2
Revenue $24.11M $22.21M
YoY Change 8.57% 6.89%
Cost Of Revenue $14.64M $13.18M
YoY Change 11.09% 8.54%
Gross Profit $9.473M $9.030M
YoY Change 4.91% 4.57%
Gross Profit Margin 39.29% 40.66%
Selling, General & Admin $6.482M $5.786M
YoY Change 12.03% 3.97%
% of Gross Profit 68.43% 64.08%
Research & Development $1.444M $1.796M
YoY Change -19.6% 31.0%
% of Gross Profit 15.24% 19.89%
Depreciation & Amortization $625.0K $455.0K
YoY Change 37.36% -11.13%
% of Gross Profit 6.6% 5.04%
Operating Expenses $7.926M $7.582M
YoY Change 4.54% 9.31%
Operating Profit $1.547M $1.448M
YoY Change 6.84% -14.77%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$52.00K $234.0K
YoY Change -122.22% -293.39%
Pretax Income $1.495M $1.682M
YoY Change -11.12% 6.59%
Income Tax $476.0K $471.0K
% Of Pretax Income 31.84% 28.0%
Net Earnings $1.019M $1.211M
YoY Change -15.85% 7.26%
Net Earnings / Revenue 4.23% 5.45%
Basic Earnings Per Share $0.14 $0.17
Diluted Earnings Per Share $0.14 $0.16
COMMON SHARES
Basic Shares Outstanding 7.358M shares 7.280M shares
Diluted Shares Outstanding 7.524M shares 7.454M shares

Balance Sheet

Concept 2016 Q2 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $23.30M $24.70M
YoY Change -5.67% -13.64%
Cash & Equivalents $14.53M $8.815M
Short-Term Investments $8.800M $15.80M
Other Short-Term Assets $2.600M $8.800M
YoY Change -70.45% 17.33%
Inventory $16.56M $14.49M
Prepaid Expenses
Receivables $15.01M $14.01M
Other Receivables $200.0K $400.0K
Total Short-Term Assets $57.67M $62.36M
YoY Change -7.52% -4.93%
LONG-TERM ASSETS
Property, Plant & Equipment $9.594M $8.678M
YoY Change 10.56% 14.74%
Goodwill $4.521M $991.0K
YoY Change 356.21% 0.0%
Intangibles $2.609M
YoY Change -19.08%
Long-Term Investments
YoY Change
Other Assets $13.47M $3.835M
YoY Change 251.26% 667.0%
Total Long-Term Assets $23.07M $12.51M
YoY Change 84.33% 144.39%
TOTAL ASSETS
Total Short-Term Assets $57.67M $62.36M
Total Long-Term Assets $23.07M $12.51M
Total Assets $80.74M $74.88M
YoY Change 7.83% -4.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.365M $4.065M
YoY Change 56.58% 63.91%
Accrued Expenses $1.917M $2.143M
YoY Change -10.55% -64.28%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $11.18M $9.239M
YoY Change 20.95% 3.59%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $900.0K $1.100M
YoY Change -18.18% 10.0%
Total Long-Term Liabilities $900.0K $1.100M
YoY Change -18.18% -8.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.18M $9.239M
Total Long-Term Liabilities $900.0K $1.100M
Total Liabilities $12.26M $10.40M
YoY Change 17.96% 2.01%
SHAREHOLDERS EQUITY
Retained Earnings $42.71M $40.43M
YoY Change 5.64% 6.98%
Common Stock $46.61M $478.0K
YoY Change 9650.42% 1.06%
Preferred Stock
YoY Change
Treasury Stock (at cost) $20.20M $19.59M
YoY Change 3.09% 49.65%
Treasury Stock Shares 2.336M shares 2.294M shares
Shareholders Equity $68.47M $64.48M
YoY Change
Total Liabilities & Shareholders Equity $80.74M $74.88M
YoY Change 7.83% -4.35%

Cashflow Statement

Concept 2016 Q2 2015 Q2
OPERATING ACTIVITIES
Net Income $1.019M $1.211M
YoY Change -15.85% 7.26%
Depreciation, Depletion And Amortization $625.0K $455.0K
YoY Change 37.36% -11.13%
Cash From Operating Activities $2.910M $2.970M
YoY Change -2.02% -219.04%
INVESTING ACTIVITIES
Capital Expenditures $195.0K $654.0K
YoY Change -70.18% 123.97%
Acquisitions
YoY Change
Other Investing Activities $1.790M -$1.170M
YoY Change -252.99% -126.23%
Cash From Investing Activities $1.590M -$1.820M
YoY Change -187.36% -143.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -560.0K -370.0K
YoY Change 51.35% -396.0%
NET CHANGE
Cash From Operating Activities 2.910M 2.970M
Cash From Investing Activities 1.590M -1.820M
Cash From Financing Activities -560.0K -370.0K
Net Change In Cash 3.940M 780.0K
YoY Change 405.13% -56.64%
FREE CASH FLOW
Cash From Operating Activities $2.910M $2.970M
Capital Expenditures $195.0K $654.0K
Free Cash Flow $2.715M $2.316M
YoY Change 17.23% -183.1%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q1 alot Debt Received Upon Sale Of Operation
DebtReceivedUponSaleOfOperation
1000000
CY2016Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7426532 shares
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8815000
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
692637 shares
CY2016Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
2335852 shares
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
13000000 shares
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.33
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
450812 shares
CY2016Q2 us-gaap Loans Receivable Basis Spread On Variable Rate
LoansReceivableBasisSpreadOnVariableRate
0.02 pure
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9714869 shares
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.04
CY2016Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
4164000
CY2016Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
46123000
CY2016Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2237000
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
68474000
CY2016Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
10000000
CY2016Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1079000
CY2016Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
584000
CY2016Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
490000
CY2016Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
6365000
CY2016Q2 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
932000
CY2016Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1917000
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
42714000
CY2016Q2 us-gaap Liabilities
Liabilities
12263000
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
80737000
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
484000
CY2016Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
166000
CY2016Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
30461000
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
11175000
CY2016Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-650000
CY2016Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
156000
CY2016Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1942012
CY2016Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13471000
CY2016Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
93000
CY2016Q2 us-gaap Assets
Assets
80737000
CY2016Q2 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
14777000
CY2016Q2 us-gaap Inventory Net
InventoryNet
16559000
CY2016Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15011000
CY2016Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
11430000
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9594000
CY2016Q2 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
8774000
CY2016Q2 us-gaap Treasury Stock Value
TreasuryStockValue
20197000
CY2016Q2 us-gaap Assets Current
AssetsCurrent
57672000
CY2016Q2 us-gaap Inventory Gross
InventoryGross
20723000
CY2016Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
6003000
CY2016Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6880000
CY2016Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
8152000
CY2016Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5801000
CY2016Q2 us-gaap Goodwill
Goodwill
4521000
CY2016Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
1141000
CY2016Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2644000
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14534000
CY2016Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
3056000
CY2016Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
40055000
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2120393
CY2016Q2 alot Revolving Line Of Credit Facility Issued Maximum Capacity
RevolvingLineOfCreditFacilityIssuedMaximumCapacity
600000
CY2016Q2 alot Amount Of Reserve For Settlement Of Liability
AmountOfReserveForSettlementOfLiability
266000
CY2016Q2 alot Line Of Credit Receivable Current
LineOfCreditReceivableCurrent
150000
CY2016Q2 alot Funded Debt To Adjusted Ebitda Ratio
FundedDebtToAdjustedEbitdaRatio
1.25 pure
CY2016Q2 alot Number Of Installments
NumberOfInstallments
16 Installment
CY2014Q1 alot Product Replacement Cost Charged Against Reserve
ProductReplacementCostChargedAgainstReserve
406000
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7958000
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
657936 shares
CY2016Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
2323545 shares
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
13000000 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.00
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9666290 shares
CY2016Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3823000
CY2016Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
45675000
CY2016Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3436000
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
67373000
CY2016Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
900000
CY2016Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
591000
CY2016Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
529000
CY2016Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3192000
CY2016Q1 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
964000
CY2016Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2209000
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
42212000
CY2016Q1 us-gaap Liabilities
Liabilities
10590000
CY2016Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
77963000
CY2016Q1 us-gaap Common Stock Value
CommonStockValue
483000
CY2016Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
182000
CY2016Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
29906000
CY2016Q1 us-gaap Liabilities Current
LiabilitiesCurrent
9548000
CY2016Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-975000
CY2016Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
78000
CY2016Q1 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
191000
CY2016Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13642000
CY2016Q1 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
92000
CY2016Q1 us-gaap Assets
Assets
77963000
CY2016Q1 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
14716000
CY2016Q1 us-gaap Inventory Net
InventoryNet
14890000
CY2016Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15325000
CY2016Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
10197000
CY2016Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9807000
CY2016Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
10376000
CY2016Q1 us-gaap Treasury Stock Value
TreasuryStockValue
20022000
CY2016Q1 us-gaap Assets Current
AssetsCurrent
54514000
CY2016Q1 us-gaap Inventory Gross
InventoryGross
18713000
CY2016Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
4340000
CY2016Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6880000
CY2016Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
7491000
CY2016Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5980000
CY2016Q1 us-gaap Goodwill
Goodwill
4521000
CY2016Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
1025000
CY2016Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3539000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10043000
CY2016Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
3049000
CY2016Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
39713000
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3083000
CY2016Q1 alot Line Of Credit Receivable Current
LineOfCreditReceivableCurrent
150000
CY2012Q1 alot Loan Receivable Interest Rate Stated Percentage
LoanReceivableInterestRateStatedPercentage
0.0375 pure
CY2014Q1 alot Settlement Amount Received From Supplier For Recovery Of Cost And Expenses
SettlementAmountReceivedFromSupplierForRecoveryOfCostAndExpenses
450000
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y1M6D
CY2013Q2 alot Estimated Replacement Cost Of Product
EstimatedReplacementCostOfProduct
672000
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2015Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
2972000
CY2015Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.016 pure
CY2015Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
244100 shares
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.227 pure
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.020 pure
CY2015Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
173936 shares
CY2015Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7454000 shares
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7280000 shares
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.43
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2015Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.280 pure
CY2015Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
654000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
1211000
CY2015Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-10000
CY2015Q2 us-gaap Sales Revenue Net
SalesRevenueNet
22206000
CY2015Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
510000
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1448000
CY2015Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1094000
CY2015Q2 us-gaap Gross Profit
GrossProfit
9030000
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
234000
CY2015Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-95000
CY2015Q2 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
600000
CY2015Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-19000
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1201000
CY2015Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
9000
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1682000
CY2015Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
207000
CY2015Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-93000
CY2016Q2 us-gaap Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
Any borrowings made under this line of credit bear interest at either a fluctuating base rate equal to the highest of (i) the Prime Rate, (ii) 1.50% above the daily one month LIBOR, and (iii) the Federal Funds Rate in effect plus 1.50% or at a fixed rate of LIBOR plus an agreed upon margin of between 0% and 2.25%, based on the Company's funded debt to EBITDA ratio as defined in the agreement.
CY2015Q2 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
3127000
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
471000
CY2015Q2 us-gaap Share Based Compensation
ShareBasedCompensation
143000
CY2015Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4329000
CY2015Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
857000
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
7582000
CY2015Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1821000
CY2015Q2 us-gaap Proceeds From Sale And Collection Of Notes Receivable
ProceedsFromSaleAndCollectionOfNotesReceivable
125000
CY2015Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-373000
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1796000
CY2015Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-397000
CY2015Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
73000
CY2015Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1457000
CY2015Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
268000
CY2015Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
79000
CY2015Q2 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
2435000
CY2015Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
89000
CY2015Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
13176000
CY2015Q2 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
2000
CY2015Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
455000
CY2015Q2 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
135000
CY2015Q2 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
10000
CY2015Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
68000
CY2015Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2015Q2 alot Procceds From Payments For Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProccedsFromPaymentsForIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
137000
CY2016Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2016Q2 us-gaap Nature Of Operations
NatureOfOperations
<div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>(1) Overview</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> On September&#xA0;25, 2015, Astro-Med, Inc. announced it would immediately begin doing business as AstroNova on a worldwide basis. The name change is part of the plan to modernize the Company and effectively communicate our strategy. The AstroNova name and brand emphasizes our traditional strengths in aerospace and acknowledges our expanding presence in test&#xA0;&amp; measurement, product identification and other new areas where we can apply our data visualization technology. On May&#xA0;18, 2016, the name change was formally approved by the Company&#x2019;s shareholders and as such the Company&#x2019;s Restated Articles of Incorporation have been amended to officially change the Company&#x2019;s name to AstroNova, Inc. The Company&#x2019;s common stock trades on the NASDAQ Global Market stock exchange under its new name, AstroNova, Inc., using the ticker symbol, ALOT.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Headquartered in West Warwick, Rhode Island, AstroNova, Inc. leverages its expertise in data visualization technologies to design, develop, manufacture and distribute a broad range of specialty printers and data acquisition and analysis systems. Our products are distributed through our own sales force and authorized dealers in the United States. We also sell to customers outside of the United States primarily through our Company offices in Canada, China, Europe, Mexico and Southeast Asia as well as with independent dealers and representatives. AstroNova, Inc. products are employed around the world in a wide range of aerospace, apparel, automotive, avionics, chemical, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging and transportation applications.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The business consists of two segments, Product Identification (previously known as our QuickLabel segment), which includes products sold under the QuickLabel<sup style="FONT-SIZE: 11px; VERTICAL-ALIGN: top">&#xAE;</sup>&#xA0;brand name, and Test&#xA0;&amp; Measurement which includes products sold under the AstroNova&#x2122; brand name.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Products sold under the QuickLabel brand are used in industrial and commercial product packaging and automatic identification applications to digitally print custom labels and other visual identification marks on demand. Products sold under the AstroNova Test&#xA0;&amp; Measurement brand acquire and record visual and electronic signal data from local and networked data streams and sensors. The recorded data is processed and analyzed and then stored and presented in various visual output formats. In the aerospace market, the Company has a long history of using its data visualization technologies to provide high-resolution airborne printers.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Unless otherwise indicated, references to &#x201C;AstroNova,&#x201D; the &#x201C;Company,&#x201D; &#x201C;we,&#x201D; &#x201C;our,&#x201D; and &#x201C;us&#x201D; in this Quarterly Report on Form&#xA0;10-Q refer to AstroNova, Inc. and its consolidated subsidiaries.</p> </div>
CY2016Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
2914000
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
2273 shares
CY2016Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2016Q2 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
0
CY2016Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 Segments
CY2016Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2016Q2 dei Amendment Flag
AmendmentFlag
false
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.015 pure
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
225 shares
CY2016Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
431133 shares
CY2016Q2 dei Document Type
DocumentType
10-Q
CY2016Q2 dei Entity Central Index Key
EntityCentralIndexKey
0000008146
CY2016Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y3M18D
CY2016Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y
CY2016Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
14.20
CY2016Q2 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2016Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
8.14
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.246 pure
CY2016Q2 us-gaap Fair Value Inputs Discount Rate
FairValueInputsDiscountRate
0.155 pure
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.019 pure
CY2016Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
15.01
CY2016Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
166661 shares
CY2016Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2016Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2016Q2 us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2017-01-31
CY2016Q2 dei Entity Registrant Name
EntityRegistrantName
AstroNova, Inc.
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7524000 shares
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
50000 shares
CY2016Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
9.14
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7358000 shares
CY2016Q2 dei Trading Symbol
TradingSymbol
ALOT
CY2016Q2 us-gaap Fair Value Measurements Significant Assumptions
FairValueMeasurementsSignificantAssumptions
Key assumptions include (1) a weighted average cost of capital of 15.5%; (2) a range of earnings projections from $110,000-$700,000 and (3) a range of contract renewal probability from 30%-100%.
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.86
CY2016Q2 dei Document Period End Date
DocumentPeriodEndDate
2016-04-30
CY2016Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
12801 shares
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2016Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.318 pure
CY2016Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
195000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
1019000
CY2016Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
325000
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
24110000
CY2016Q2 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
325000
CY2016Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
516000
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1547000
CY2016Q2 us-gaap Gross Profit
GrossProfit
9473000
CY2016Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-52000
CY2016Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1588000
CY2016Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-443000
CY2016Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2000
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1344000
CY2016Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
327000
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1495000
CY2016Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
170000
CY2016Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-128000
CY2016Q2 us-gaap Line Of Credit Facility Average Outstanding Amount
LineOfCreditFacilityAverageOutstandingAmount
0
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
476000
CY2016Q2 us-gaap Share Based Compensation
ShareBasedCompensation
314000
CY2016Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4831000
CY2016Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4491000
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
7926000
CY2016Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
1591000
CY2016Q2 us-gaap Proceeds From Sale And Collection Of Notes Receivable
ProceedsFromSaleAndCollectionOfNotesReceivable
188000
CY2016Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-556000
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1444000
CY2016Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1647000
CY2016Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
81000
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1651000
CY2016Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
257000
CY2016Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
542000
CY2016Q2 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1598000
CY2016Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
179000
CY2016Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
14637000
CY2016Q2 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
3000
CY2016Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
625000
CY2016Q2 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
CY2016Q2 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
52000
CY2016Q2 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
69000
CY2016Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
230000
CY2016Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2016Q2 alot Non Employee Director Received Restricted Stock Award Value
NonEmployeeDirectorReceivedRestrictedStockAwardValue
20000
CY2016Q2 alot Loan Receivable Date Considered For Interest Payments
LoanReceivableDateConsideredForInterestPayments
2013-01-30
CY2016Q2 alot Reservation Of Shares Under Employee Stock Purchase Plan
ReservationOfSharesUnderEmployeeStockPurchasePlan
247500 shares
CY2016Q2 alot Maximum Disposal Restriction As Percentage Of Restricted Stock Units
MaximumDisposalRestrictionAsPercentageOfRestrictedStockUnits
0.50 pure
CY2016Q2 alot Number Of Equity Incentive Plans
NumberOfEquityIncentivePlans
2 Equity_Plan
CY2016Q2 alot Fixed Charge Coverage Ratio
FixedChargeCoverageRatio
3 pure
CY2016Q2 alot Period To Receive Lower Product Prices From Supplier Description
PeriodToReceiveLowerProductPricesFromSupplierDescription
Through fiscal 2017
CY2016Q2 alot Procceds From Payments For Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProccedsFromPaymentsForIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
-40000
CY2015Q3 alot Fees To Non Employee Director
FeesToNonEmployeeDirector
7000

Files In Submission

Name View Source Status
0001193125-16-613905-index-headers.html Edgar Link pending
0001193125-16-613905-index.html Edgar Link pending
0001193125-16-613905.txt Edgar Link pending
0001193125-16-613905-xbrl.zip Edgar Link pending
alot-20160430.xml Edgar Link completed
alot-20160430.xsd Edgar Link pending
alot-20160430_cal.xml Edgar Link unprocessable
alot-20160430_def.xml Edgar Link unprocessable
alot-20160430_lab.xml Edgar Link unprocessable
alot-20160430_pre.xml Edgar Link unprocessable
d171895d10q.htm Edgar Link pending
d171895dex311.htm Edgar Link pending
d171895dex312.htm Edgar Link pending
d171895dex321.htm Edgar Link pending
d171895dex322.htm Edgar Link pending
d171895dex3a.htm Edgar Link pending
d171895dex41.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g171895ex3apg02a.jpg Edgar Link pending
g171895ex3apg02b.jpg Edgar Link pending
g171895ex3apg05a.jpg Edgar Link pending
g171895ex3apg05b.jpg Edgar Link pending
g171895ex3apg08a.jpg Edgar Link pending
g171895ex3apg08b.jpg Edgar Link pending
g171895ex3apg13a.jpg Edgar Link pending
g171895ex3apg13b.jpg Edgar Link pending
g171895ex3apg13c.jpg Edgar Link pending
g171895ex41pg1new.jpg Edgar Link pending
g171895ex41pg2a.jpg Edgar Link pending
g171895ex41pg2b.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending